99% Stéroïdes masculins d'amélioration de pureté Avanafil
Informations de base
| Nom du produit |
Avanafil |
| Alias |
Avanafil |
| CAS |
330784-47-9 |
| MF |
C23H26ClN7O3 |
| MW |
483.9506 |
| Pureté |
99% |
| Classe |
Qualité pharmaceutique |
| Apparence |
white Crystalline Powder |
| Brand Nmae |
HKYC |
| Standard |
USP, BP |
| Durée de conservation |
2 années |
| Stradge |
Keep in a ventilated, dry and cool place |
| Stock |
Mass Stock |
| Packing Methods |
designed disguised packing ways, 100% pass custom guarantee |
| Delivery time |
dans 18 hours after payment confirmed |
| Paiement |
T/T, Western union,Gramme d'argent |
La description:
Avanafil is a PDE5 inhibitor approved for erectile dysfunction by FDA on April 27, 2012 and by EMA on June 21, 2013. Avanafil is known by the trademark names and Spedra and was developed by Vivus Inc. Avanafil acts by inhibiting a specific phosphodiesterase type 5 enzyme which is found in various body tissues, but primarily in the corpus cavernosum penis, as well as the retina. Other similar drugs are tadalafil and vardenafil. The advantage of avanafil is that it has very fast onset of action compared with other PDE5 inhibitors. It is absorbed quickly, reaching a maximum concentration in about 30-45 minutes. About two-thirds of the participants were able to engage in sexual activity within 15 minutes..
Application:
Avanafil relaxes muscles of the blood vessels and increases blood flow to particular areas of the body.
Avanafil is used to treat erectile dysfunction (impotence).
Avanafil may also be used for purposes not listed in this medication guide.
Directeur commercial